Eton Pharmaceuticals, Inc.·4

Mar 8, 4:31 PM ET

Troutman William Wilson 4

4 · Eton Pharmaceuticals, Inc. · Filed Mar 8, 2019

Insider Transaction Report

Form 4
Period: 2019-02-20
Troutman William Wilson
CFO, Treasurer & Secretary
Transactions
  • Award

    Stock option (right to buy)

    2019-02-20+95,00095,000 total
    Exercise: $7.31Exp: 2029-02-19Common Stock (95,000 underlying)
Footnotes (1)
  • [F1]The shares subject to the option shall vest in 48 equal monthly installments from the date of grant until fully vested and exercisable on February 20, 2023.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION